DEVELOPMENT OF CRISPR-CAS9 DELIVERY SYSTEM BASED ON LIPID NANOPARTICLES TARGETED TO TGF-?1 GENE AND ACTIVITY TEST IN VITRO
Diabetic nephropathy (DN) is a microvascular disease triggered by hyperglycemic conditions that can lead to end-stage renal disease. A major obstacle in the conventional treatment of DN is the low effectiveness of drugs, as current therapies focus primarily on symptomatic relief rather than addre...
Saved in:
主要作者: | |
---|---|
格式: | Dissertations |
語言: | Indonesia |
在線閱讀: | https://digilib.itb.ac.id/gdl/view/86154 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | Institut Teknologi Bandung |
語言: | Indonesia |